mhurhangee/ep-ind-claims huggingface dataset:
A method for the manufacture of a cream cheese, the method comprising: (i) providing a first dairy liquid; (ii) fermenting the first dairy liquid to form a first acidified dairy liquid; (iii) providing a second dairy liquid; (iv) acidifying the second dairy liquid with citric acid to form a second acidified dairy liquid; (v) combining the first acidified dairy liquid and the second acidified dairy liquid to form a cream cheese. (i) providing a first dairy liquid; (ii) fermenting the first dairy liquid to form a first acidified dairy liquid; (iii) providing a second dairy liquid; (iv) acidifying the second dairy liquid with citric acid to form a second acidified dairy liquid; (v) combining the first acidified dairy liquid and the second acidified dairy liquid to form a cream cheese.
Single line for a charging cable, comprising a) an open support structure (011, 012) with a longitudinal extent, b) a conductor netting of conductors and c) an insulation, wherein d) the conductor netting envelops the open support structure (011, 012) directly along its longitudinal extent and e) the insulation envelops the open support structure (011, 012) and the conductor netting and f) there is at least one channel for a cooling fluid and this channel is formed by the support structure (011, 012) and the conductor netting, and g) wherein the conductor netting is in particular permeable for the cooling fluid and h) wherein the insulation is impermeable for the cooling fluid and is electrically insulating, characterised in that i) the conductor netting is along its longitudinal extent surrounded by further conductors (21, 22) which are in electrical contact with the conductor netting, wherein the further conductors (21, 22) either are themselves formed as one or several netting/s which are arranged coaxially around the conductor netting or are twisted around the conductor netting, j) and wherein the open support structure is an elongate structure whose convex envelope has the shape of a cylinder, wherein at least one through-channel, i. e. a channel that is not interrupted by the structure, extends along and within the convex envelope. a) an open support structure (011, 012) with a longitudinal extent, b) a conductor netting of conductors and c) an insulation, wherein d) the conductor netting envelops the open support structure (011, 012) directly along its longitudinal extent and e) the insulation envelops the open support structure (011, 012) and the conductor netting and f) there is at least one channel for a cooling fluid and this channel is formed by the support structure (011, 012) and the conductor netting, and g) wherein the conductor netting is in particular permeable for the cooling fluid and h) wherein the insulation is impermeable for the cooling fluid and is electrically insulating, characterised in that i) the conductor netting is along its longitudinal extent surrounded by further conductors (21, 22) which are in electrical contact with the conductor netting, wherein the further conductors (21, 22) either are themselves formed as one or several netting/s which are arranged coaxially around the conductor netting or are twisted around the conductor netting, j) and wherein the open support structure is an elongate structure whose convex envelope has the shape of a cylinder, wherein at least one through-channel, i. e. a channel that is not interrupted by the structure, extends along and within the convex envelope.
A CRISPR/Cas9 recombinant vector for targeted knockout of S-RNase protein genes, characterized in that the nucleotide sequence of the S-RNase protein targeted by the CRISPR/Cas9 recombinant vector is the sequence shown in SEQ ID NO:2 (S p3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (S p4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof; wherein the nucleotide sequence in the CRISPR/Cas9 recombinant vector comprises: S-RNase P3 (i.e., Seq ID No:4): xxxxACGATTCACGGGCTTTGGC, and S-RNase P4 (i.e., Seq ID No:5): xxxxGCCAAAGCCCGTGAATCGT; wherein, in Seq ID No.4 and Seq ID No.5, xxxx is a cohesive end for ligation of the vector. S-RNase P3 (i.e., Seq ID No:4): xxxxACGATTCACGGGCTTTGGC, and S-RNase P4 (i.e., Seq ID No:5): xxxxGCCAAAGCCCGTGAATCGT; wherein, in Seq ID No.4 and Seq ID No.5, xxxx is a cohesive end for ligation of the vector.
A ring gear, comprising: a cylindrical ring gear body having a wall with a longitudinal length extending between opposing first and second ends, the wall having an outer surface and an inner surface, wherein the inner surface has a first portion that extends a first sub-length of the ring gear body and a longitudinally spaced apart second portion that extends a second sub-length of the ring gear body, wherein the first portion extends from the first end of the ring gear inward and the second portion extends from the second end of the ring gear inward, wherein the inner surface of the first portion comprises a plurality of longitudinally extending splines and the inner surface of the second portion is devoid of the splines of the first portion said ring gear being in combination with a disk-shaped torque transducer, wherein the disk-shaped torque transducer has a longitudinally extending outer wall with opposing first and second ends and a length therebetween, wherein the outer wall merges radially inward into a thin circular interior flat wall that surrounds a center hub defining an axially extending open channel, characterized in that the transducer outer wall length is the same or less than the sub-length of the second portion of the ring gear, and wherein the transducer outer wall resides encased in the second portion of the ring gear so that the transducer outer wall is fully covered. a cylindrical ring gear body having a wall with a longitudinal length extending between opposing first and second ends, the wall having an outer surface and an inner surface, wherein the inner surface has a first portion that extends a first sub-length of the ring gear body and a longitudinally spaced apart second portion that extends a second sub-length of the ring gear body, wherein the first portion extends from the first end of the ring gear inward and the second portion extends from the second end of the ring gear inward, wherein the inner surface of the first portion comprises a plurality of longitudinally extending splines and the inner surface of the second portion is devoid of the splines of the first portion said ring gear being in combination with a disk-shaped torque transducer, wherein the disk-shaped torque transducer has a longitudinally extending outer wall with opposing first and second ends and a length therebetween, wherein the outer wall merges radially inward into a thin circular interior flat wall that surrounds a center hub defining an axially extending open channel, characterized in that the transducer outer wall length is the same or less than the sub-length of the second portion of the ring gear, and wherein the transducer outer wall resides encased in the second portion of the ring gear so that the transducer outer wall is fully covered.
A system for mobility management, comprising: a source cell set, configured to: obtain cell set information from a cell set in an access network; select, according to the cell set information, a target cell set to which a user equipment, UE, may handover; and send information about the selected target cell set to the target cell set; the target cell set, configured to: decide two target cells served by the target cell set according to the information about the selected target cell set and a resource occupation state of the target cell set; and send information about the two target cells to the source cell set, wherein the source cell set is further configured to send the information about the two target cells to the UE, and wherein the two target cells comprise an anchor cell and one target cell other than the anchor cell. a source cell set, configured to: obtain cell set information from a cell set in an access network; select, according to the cell set information, a target cell set to which a user equipment, UE, may handover; and send information about the selected target cell set to the target cell set; obtain cell set information from a cell set in an access network; select, according to the cell set information, a target cell set to which a user equipment, UE, may handover; and send information about the selected target cell set to the target cell set; the target cell set, configured to: decide two target cells served by the target cell set according to the information about the selected target cell set and a resource occupation state of the target cell set; and send information about the two target cells to the source cell set, wherein the source cell set is further configured to send the information about the two target cells to the UE, and wherein the two target cells comprise an anchor cell and one target cell other than the anchor cell. decide two target cells served by the target cell set according to the information about the selected target cell set and a resource occupation state of the target cell set; and send information about the two target cells to the source cell set, wherein the source cell set is further configured to send the information about the two target cells to the UE, and wherein the two target cells comprise an anchor cell and one target cell other than the anchor cell.
An isolated anti-PD-Ll antibody, or an antigen-binding fragment thereof, comprising a heavy chain variable region and a light chain variable region, wherein the heavy chain variable region comprises: (i) an HVR-H1 comprising the sequence of GFSLTSYDIS (SEQ ID NO: 4); (ii) an HVR-H2 comprising the sequence of VIWTGVGTN (SEQ ID NO: 5); and (iii) an HVR-H3 comprising the sequence of DPYYYGMDY (SEQ ID NO: 6); and the light chain variable region comprises: (iv) an HVR-L1 comprising the sequence of RASQDISIWLS (SEQ ID NO: 1); (v) an HVR-L2 comprising the sequence of KASNLHT (SEQ ID NO: 2); and (vi) an HVR-L3 comprising the sequence of LQSQSFPRT (SEQ ID NO: 3). (i) an HVR-H1 comprising the sequence of GFSLTSYDIS (SEQ ID NO: 4); (ii) an HVR-H2 comprising the sequence of VIWTGVGTN (SEQ ID NO: 5); and (iii) an HVR-H3 comprising the sequence of DPYYYGMDY (SEQ ID NO: 6); (iv) an HVR-L1 comprising the sequence of RASQDISIWLS (SEQ ID NO: 1); (v) an HVR-L2 comprising the sequence of KASNLHT (SEQ ID NO: 2); and (vi) an HVR-L3 comprising the sequence of LQSQSFPRT (SEQ ID NO: 3).
A solid pharmaceutical composition comprising a) a pharmaceutically effective amount of a compound of Formula dispersed in a hydroxypropyl methylcellulose acetate succinate (HPMCAS) polymer matrix; and b) a pharmaceutically acceptable carrier; wherein the compound of Formula is present in substantially an amorphous form; and wherein the pharmaceutical composition is a tablet. a) a pharmaceutically effective amount of a compound of Formula dispersed in a hydroxypropyl methylcellulose acetate succinate (HPMCAS) polymer matrix; and b) a pharmaceutically acceptable carrier; wherein the compound of Formula is present in substantially an amorphous form; and wherein the pharmaceutical composition is a tablet. wherein the compound of Formula is present in substantially an amorphous form; and wherein the pharmaceutical composition is a tablet.
An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of: a) a nucleic acid sequence encoding a protein consisting of the amino acid sequence SEQ ID NO:32; b) a nucleic acid sequence encoding an amino acid sequence with xylanase activity that is at least 90% identical to a full length amino acid sequence of (a); c) a nucleic acid sequence selected from the group consisting of: SEQ ID NO:31, and SEQ ID NO:33; d) a nucleic acid sequence that is fully complementary to the nucleic acid sequences of (a), (b)or (c). a) a nucleic acid sequence encoding a protein consisting of the amino acid sequence SEQ ID NO:32; b) a nucleic acid sequence encoding an amino acid sequence with xylanase activity that is at least 90% identical to a full length amino acid sequence of (a); c) a nucleic acid sequence selected from the group consisting of: SEQ ID NO:31, and SEQ ID NO:33; d) a nucleic acid sequence that is fully complementary to the nucleic acid sequences of (a), (b)or (c).
A method of testing for efficacy of a potential drug agent against cancerous cells in a rodent, comprising: (i) transferring cancer cells into the rodent; (ii) contacting the cancer cells with a potential drug agent by administering the potential drug agent to the rodent; and (iii) measuring effect of the potential drug agent on the cancer cells, wherein reduction of number of cancer cells in the rodentis indicative of efficaciousness of the potential drug agent against cancerous cells, wherein the method comprises contacting the cancer cells with an agent that maintains stem cells in the naive state or reverts primed stem cells to the naive state before carrying out step (i), after carrying out step (i), or both before and after carrying out step (i), wherein the agent that maintains stem cells in the naive state or reverts primed stem cells to the naive state is an NME protein. (i) transferring cancer cells into the rodent; (ii) contacting the cancer cells with a potential drug agent by administering the potential drug agent to the rodent; and (iii) measuring effect of the potential drug agent on the cancer cells, wherein reduction of number of cancer cells in the rodentis indicative of efficaciousness of the potential drug agent against cancerous cells, wherein the method comprises contacting the cancer cells with an agent that maintains stem cells in the naive state or reverts primed stem cells to the naive state before carrying out step (i), after carrying out step (i), or both before and after carrying out step (i), wherein the agent that maintains stem cells in the naive state or reverts primed stem cells to the naive state is an NME protein.
Device for preparing infused drinks comprising: - a support arranged to receive a capsule containing material to be infused in dry state provided with a front face comprising a filter wall, a ring surrounding said front face, a rear face, opposite said front face and a solid casing extending between said ring and said rear face and defining a container arranged to contain said material to be infused, in a position in which said front face is substantially vertical, - injection means arranged to introduce an infusion liquid into said capsule, when said support receives a capsule, - an infusion chamber having a substantially vertical opening, said substantially vertical opening being arranged to be in fluid communication with said filter wall, said ring comprising sealing means arranged to maintain the fluid communication sealed with respect to a surrounding medium, outside a fluid exchange zone, and - an outlet provided with closing/opening means arranged to allow an infused liquid to flow from the infusion chamber, characterised in that it further comprises a pipe for injecting said infusion liquid connected to an upper portion of said infusion chamber in the vicinity of said substantially vertical opening. - a support arranged to receive a capsule containing material to be infused in dry state provided with a front face comprising a filter wall, a ring surrounding said front face, a rear face, opposite said front face and a solid casing extending between said ring and said rear face and defining a container arranged to contain said material to be infused, in a position in which said front face is substantially vertical, - injection means arranged to introduce an infusion liquid into said capsule, when said support receives a capsule, - an infusion chamber having a substantially vertical opening, said substantially vertical opening being arranged to be in fluid communication with said filter wall, said ring comprising sealing means arranged to maintain the fluid communication sealed with respect to a surrounding medium, outside a fluid exchange zone, and - an outlet provided with closing/opening means arranged to allow an infused liquid to flow from the infusion chamber, characterised in that it further comprises a pipe for injecting said infusion liquid connected to an upper portion of said infusion chamber in the vicinity of said substantially vertical opening.
A reversible bone coupling device comprising: a first component comprising: a first elongated stem portion for insertion from a first end longitudinally into a surface of a first bone piece; and a second component comprising: a second elongated stem portion for insertion from a second end longitudinally into a surface of a second bone piece, and a connector extending from a second top and comprising a plurality of grooves for coupling with the first component and locking therein, wherein the first component comprises a cavity that extends within the first elongated stem portion from a first top toward the first end, the cavity capable of receiving the connector of the second component, and wherein the first component includes a reversibly engaging locking mechanism characterised in that the cavity includes an inner surface with a plurality of lobes, and in that the locking mechanism comprises an internal lock ring positioned within the cavity of the first component for selectively engaging and disengaging the connector relative to the first component, the internal lock ring including outwardly-facing bosses positioned within the lobes of the cavity and an inwardly-facing chamfer for engaging the grooves of the connector. a first component comprising: a first elongated stem portion for insertion from a first end longitudinally into a surface of a first bone piece; and a first elongated stem portion for insertion from a first end longitudinally into a surface of a first bone piece; and a second component comprising: a second elongated stem portion for insertion from a second end longitudinally into a surface of a second bone piece, and a connector extending from a second top and comprising a plurality of grooves for coupling with the first component and locking therein, wherein the first component comprises a cavity that extends within the first elongated stem portion from a first top toward the first end, the cavity capable of receiving the connector of the second component, and a second elongated stem portion for insertion from a second end longitudinally into a surface of a second bone piece, and a connector extending from a second top and comprising a plurality of grooves for coupling with the first component and locking therein, wherein the first component comprises a cavity that extends within the first elongated stem portion from a first top toward the first end, the cavity capable of receiving the connector of the second component, and wherein the first component includes a reversibly engaging locking mechanism characterised in that the cavity includes an inner surface with a plurality of lobes, and in that the locking mechanism comprises an internal lock ring positioned within the cavity of the first component for selectively engaging and disengaging the connector relative to the first component, the internal lock ring including outwardly-facing bosses positioned within the lobes of the cavity and an inwardly-facing chamfer for engaging the grooves of the connector.
Transmitter device for a system of distributed interference cancelation based on delayed channel gain information for a plurality of transmitters and respective receivers, wherein the transmitter device is configured to: apply repetition coding to a symbol stream to be transmitted to obtain an encoded symbol stream; apply a distributed interference compression to said symbol stream and to delayed channel gain information, to obtain a compressed interference signal; and transmit a signal of said encoded symbol stream and said compressed interference signal; wherein said distributed interference compression is calculated such that the interference generated by each transmitter is the same, at the receivers, after distributed interference compression by each receiver. apply repetition coding to a symbol stream to be transmitted to obtain an encoded symbol stream; apply a distributed interference compression to said symbol stream and to delayed channel gain information, to obtain a compressed interference signal; and transmit a signal of said encoded symbol stream and said compressed interference signal; wherein said distributed interference compression is calculated such that the interference generated by each transmitter is the same, at the receivers, after distributed interference compression by each receiver.
Stator coil arrangement for a permanent magnet electric rotary machine, comprising: • a ferromagnetic core; • at least one winding of a conductor wound around said ferromagnetic core, wherein said at least one winding is centred along a magnetic axis through said ferromagnetic core; • wherein said ferromagnetic core comprises a compound comprising a polymer matrix composition and a functional filler, the functional filler comprising a ferromagnetic material, characterized by • said ferromagnetic core comprising at least one fluid channel extending through said core for removing excess heat from the core; wherein • said magnetic axis of said ferromagnetic core being substantially parallel to the at least one fluid channel in said ferromagnetic core; and wherein • said polymer matrix composition has a thermal conductivity of at least 0.1 W/mK. • a ferromagnetic core; • at least one winding of a conductor wound around said ferromagnetic core, wherein said at least one winding is centred along a magnetic axis through said ferromagnetic core; • wherein said ferromagnetic core comprises a compound comprising a polymer matrix composition and a functional filler, the functional filler comprising a ferromagnetic material, • said ferromagnetic core comprising at least one fluid channel extending through said core for removing excess heat from the core; wherein • said magnetic axis of said ferromagnetic core being substantially parallel to the at least one fluid channel in said ferromagnetic core; and wherein • said polymer matrix composition has a thermal conductivity of at least 0.1 W/mK.